Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network

Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network

Background Safety of dupilumab in atopic dermatitis (AD) was investigated in randomized controlled trials (RCT). However, head-to-head trials comparing with conventional systemic drugs are lacking and large real-world data on the long-term safety profile as compared are scarce.Objective To compare l...

Full description

Saved in:
Bibliographic Details
Main Authors: Henner Zirpel, Ralf J. Ludwig, Henning Olbrich, Khalaf Kridin, Sascha Ständer, Diamant Thaçi
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Atopic dermatitis
dupilumab
safety
risk
comorbidities
conventional systemic therapy
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2421429
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items